Ca2+-activated K+ channels mediate relaxation of forearm veins in chronic renal failure

J Hypertens. 2003 Oct;21(10):1927-34. doi: 10.1097/00004872-200310000-00021.

Abstract

Background: In arteries, agonists such as acetylcholine release an endothelium-derived hyperpolarizing factor (EDHF) that is neither nitric oxide nor prostacyclin.

Objectives: To examine the responses to acetylcholine in segments of forearm veins from patients with chronic renal failure who either had never received dialysis or had undergone long-term dialysis, and to determine the contribution of nitric oxide and EDHF to endothelium-dependent relaxation in veins from patients with chronic renal failure.

Methods: Isometric tension was recorded in rings of forearm vein from 34 non-dialysed patients, 27 dialysed patients and 14 multiorgan donors (controls).

Results: Relaxation in response to acetylcholine was reduced in veins of non-dialysed and dialysed patients. The inhibitors of nitric oxide synthase NG-monomethyl-l-arginine (l-NMMA) and NG,NG-dimethyl-l-arginine (ADMA) reduced by 50% the maximum relaxation in response to acetylcholine in veins from controls and non-dialysed patients; the remaining relaxation was inhibited by 20 mmol/l KCl or by the K+ channel blockers tetraethylammonium chloride, iberiotoxin, charybdotoxin and the combination of barium plus ouabain, but not by apamin or glibenclamide. Relaxation in veins from dialysed patients was inhibited by K+ channel blockade but not by l-NMMA or ADMA.

Conclusions: The results demonstrate that the endothelium-dependent relaxation in forearm veins from controls and non-dialysed patients is mediated by release of nitric oxide and EDHF. In contrast, the relaxation in veins from dialysed patients is mediated mainly by EDHF. EDHF-induced relaxation involves activation of large-conductance Ca2+-activated K+ channels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholine / pharmacology
  • Biological Factors / metabolism
  • Enzyme Inhibitors / pharmacology
  • Female
  • Forearm / blood supply
  • Humans
  • In Vitro Techniques
  • Kidney Failure, Chronic / metabolism*
  • Kidney Failure, Chronic / physiopathology*
  • Male
  • Middle Aged
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitroprusside / pharmacology
  • Oxadiazoles / pharmacology
  • Potassium Channels, Calcium-Activated / antagonists & inhibitors
  • Potassium Channels, Calcium-Activated / metabolism*
  • Quinoxalines / pharmacology
  • Vasodilation / drug effects
  • Vasodilation / physiology*
  • Vasodilator Agents / pharmacology
  • Veins / physiology
  • omega-N-Methylarginine / pharmacology

Substances

  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Biological Factors
  • Enzyme Inhibitors
  • Oxadiazoles
  • Potassium Channels, Calcium-Activated
  • Quinoxalines
  • Vasodilator Agents
  • endothelium-dependent hyperpolarization factor
  • Nitroprusside
  • omega-N-Methylarginine
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Acetylcholine